Estimating Global Friction Periods for Economic Evaluation: A Case Study of Selected OECD Member Countries

Paul Hanly, Marta Ortega Ortega, Alison Pearce, Marianna de Camargo Cancela, Isabelle Soerjomataram, Linda Sharp

Open source

DOI: 10.1007/s40273-023-01261-y
Published: 2023-04-10
Container: PharmacoEconomics
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s40273-023-01261-y,
  title = {Estimating Global Friction Periods for Economic Evaluation: A Case Study of Selected OECD Member Countries},
  author = {Paul Hanly and Marta Ortega Ortega and Alison Pearce and Marianna de Camargo Cancela and Isabelle Soerjomataram and Linda Sharp},
  year = {2023},
  journal = {PharmacoEconomics},
  doi = {10.1007/s40273-023-01261-y},
  url = {https://doi.org/10.1007/s40273-023-01261-y}
}

RIS

TY  - JOUR
TI  - Estimating Global Friction Periods for Economic Evaluation: A Case Study of Selected OECD Member Countries
AU  - Paul Hanly
AU  - Marta Ortega Ortega
AU  - Alison Pearce
AU  - Marianna de Camargo Cancela
AU  - Isabelle Soerjomataram
AU  - Linda Sharp
PY  - 2023
JO  - PharmacoEconomics
DO  - 10.1007/s40273-023-01261-y
UR  - https://doi.org/10.1007/s40273-023-01261-y
ER  -

APA

Hanly, P., Ortega, M. O., Pearce, A., Cancela, M. D. C., Soerjomataram, I., & Sharp, L. (2023). Estimating Global Friction Periods for Economic Evaluation: A Case Study of Selected OECD Member Countries. PharmacoEconomics. https://doi.org/10.1007/s40273-023-01261-y

Source records

crossref · retrieved 2026-11-11T03:54:42.910Z